Stanford Breakthrough: Stem Cell Transplants Without Toxic Chemo or Radiation
A Phase 1 clinical trial has shown that an antibody developed at Stanford Medicine can prepare patients for stem cell transplantation while avoiding toxic side effects. A phase 1 clinical…